120 related articles for article (PubMed ID: 18568913)
1. In situ intestinal absorption of cyclosporine A solid dispersion in rats.
Liu C; Zhu S; Zhou Y; Wei Y; Pei Y
Drug Dev Ind Pharm; 2008 Jun; 34(6):627-31. PubMed ID: 18568913
[TBL] [Abstract][Full Text] [Related]
2. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation.
Fricker G; Drewe J; Huwyler J; Gutmann H; Beglinger C
Br J Pharmacol; 1996 Aug; 118(7):1841-7. PubMed ID: 8842452
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of dissolution of cyclosporine A using solid dispersions with polyoxyethylene (40) stearate.
Liu C; Zhu SJ; Zhou Y; Wei YP; Pei YY
Pharmazie; 2006 Aug; 61(8):681-4. PubMed ID: 16964710
[TBL] [Abstract][Full Text] [Related]
4. Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension.
Bravo González RC; Huwyler J; Walter I; Mountfield R; Bittner B
Int J Pharm; 2002 Oct; 245(1-2):143-51. PubMed ID: 12270251
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN).
Ugazio E; Cavalli R; Gasco MR
Int J Pharm; 2002 Jul; 241(2):341-4. PubMed ID: 12100861
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier.
Zhang Y; Li X; Zhou Y; Fan Y; Wang X; Huang Y; Liu Y
Mol Pharm; 2010 Aug; 7(4):1169-82. PubMed ID: 20540526
[TBL] [Abstract][Full Text] [Related]
7. The absorption behavior of cyclosporin A lecithin vesicles in rat intestinal tissue.
Chen Y; Ping Q; Guo J; Lv W; Gao J
Int J Pharm; 2003 Aug; 261(1-2):21-6. PubMed ID: 12878392
[TBL] [Abstract][Full Text] [Related]
8. Equivalence of cyclosporine blood level assays in patients receiving cyclosporine microemulsion or cyclosporine. The Sandoz Neoral Study Group N103.
Pescovitz MD; Wong RL; Choc MG; Chang CT
Clin Transplant; 1997 Oct; 11(5 Pt 1):442-5. PubMed ID: 9361938
[TBL] [Abstract][Full Text] [Related]
9. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of cyclosporine A loaded mPEG-PLGA copolymer micelles and study its pharmacokinetics in rats].
Yao DG; Sun KX; Mu HJ; Zhou FM; Chen HH; Liu LJ; Liang N
Yao Xue Xue Bao; 2009 Dec; 44(12):1410-5. PubMed ID: 21351479
[TBL] [Abstract][Full Text] [Related]
11. Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A.
Dai W; Guo Y; Zhang H; Wang X; Zhang Q
Int J Pharm; 2015 Jan; 478(2):718-25. PubMed ID: 25448562
[TBL] [Abstract][Full Text] [Related]
12. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine.
Park MJ; Balakrishnan P; Yang SG
Int J Pharm; 2013 Jan; 441(1-2):757-64. PubMed ID: 23089581
[TBL] [Abstract][Full Text] [Related]
13. Intestinal absorption mechanism of rotundic acid: Involvement of P-gp and OATP2B1.
Shang H; Sun Y; Wang Z; Zhou Y; Yang H; Ci X; Cui T; Xia Y; Gu Y; Liao M; Li Q; Si D; Liu C
J Ethnopharmacol; 2022 May; 289():115006. PubMed ID: 35051604
[TBL] [Abstract][Full Text] [Related]
14. Effect of streptozotocin-induced diabetes on cyclosporin A disposition in rats.
Ogata M; Iizuka Y; Murata R; Hikichi N
Biol Pharm Bull; 1996 Dec; 19(12):1586-90. PubMed ID: 8996644
[TBL] [Abstract][Full Text] [Related]
15. Capsaicin pretreatment increased the bioavailability of cyclosporin in rats: involvement of P-glycoprotein and CYP 3A inhibition.
Zhai XJ; Shi F; Chen F; Lu YN
Food Chem Toxicol; 2013 Dec; 62():323-8. PubMed ID: 24013073
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
[TBL] [Abstract][Full Text] [Related]
17. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
18. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
Jin M; Shimada T; Yokogawa K; Nomura M; Kato Y; Tsuji A; Miyamoto K
Int J Pharm; 2006 Feb; 309(1-2):81-6. PubMed ID: 16384676
[TBL] [Abstract][Full Text] [Related]
19. Factors that affect absorption behavior of cyclosporin a in gentamicin-induced acute renal failure in rats.
Shibata N; Morimoto J; Hoshino N; Minouchi T; Yamaji A
Ren Fail; 2000 Mar; 22(2):181-94. PubMed ID: 10803762
[TBL] [Abstract][Full Text] [Related]
20. Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine.
Jin M; Shimada T; Shintani M; Yokogawa K; Nomura M; Miyamoto K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):324-30. PubMed ID: 16272749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
